Nest.Bio Ventures
Active
16
19M
10
2.00
0.38
1
- Stages of investment
- Areas of investment
Summary
Nest.Bio Ventures is the famous VC, which was founded in 2016. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Boston.
The typical startup value when the investment from Nest.Bio Ventures is 100-500 millions dollars. The fund is constantly included in 2-6 deals per year. The high activity for fund was in 2018. The usual things for fund are deals in the range of 10 - 50 millions dollars. This Nest.Bio Ventures works on 18 percentage points less the average amount of lead investments comparing to the other organizations.
Besides them, we counted 4 critical employees of this fund in our database.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Nest.Bio Ventures, startups are often financed by Vivo Capital, Viventures, U.S. Department of Defense. The meaningful sponsors for the fund in investment in the same round are Viventures, Sequoia Capital China, Qiming Venture Partners. In the next rounds fund is usually obtained by Sequoia Capital China, Legend Star, LYFE Capital.
Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Senti Biosciences, HiFiBiO, RootPath Genomics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. When startup sums 1 of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Medical, Biopharma.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 16
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 2.00
- Follow on index
- 0.38
- Investments by industry
- Biotechnology (14)
- Therapeutics (6)
- Health Care (4)
- Artificial Intelligence (4)
- Biopharma (4) Show 12 more
- Investments by region
-
- United States (12)
- France (2)
- Singapore (1)
- China (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 21M
- Group Appearance index
- 0.08
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Astrocyte Pharmaceuticals | 06 Jun 2018 | Biotechnology, Pharmaceutical, Therapeutics, Clinical Trials | Seed | 2M | United States, Massachusetts, Cambridge |
| PerShop | 18 Mar 2019 | E-Commerce, Apps | Seed | 150K | United States, California, San Francisco |
| Platelet BioGenesis | 09 Sep 2019 | Biotechnology, Life Science, Ediscovery | Early Stage Venture | 26M | United States, Massachusetts, Newton |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.